EC Neurology

Review Article Volume 15 Issue 6 - 2023

Unlocking the Power of Stem Cells: Revolutionizing Alzheimer’s Disease Management with Cutting-Edge Solutions

Talha Sultan1*, Muhammad Iftikhar Hanif2, Siamak Sarrafan3 and Mehwish Sultan Ahmed4

1Center for Applied Molecular Biology and Forensic Science (CAMB), University of the Punjab, Pakistan
2Faculty of Medicine, AIMST University, Kedah, Malaysia
3International Medical School, MSU, Malaysia
4College of Agriculture, University of Sargodha, Pakistan

*Corresponding Author: Talha Sultan, Center for Applied Molecular Biology and Forensic Science (CAMB), University of the Punjab, Lahore, Pakistan.
Received: June 01, 2023; Published: June 19, 2023

Stem cells possess immense potential in revolutionizing the management of Alzheimer's disease. They have the ability to repair and rejuvenate the affected brain, stimulate the growth of new neurons, and offer tailored treatments. Collaboration among researchers, clinicians, and industry stakeholders is essential for driving progress and translating scientific advancements into practical solutions for Alzheimer's. Stem cell therapy introduces an innovative approach to address the fundamental causes of the disease by replacing damaged cells and potentially slowing down its progression. However, we must tackle challenges such as safety, ethical concerns, delivery methods, and long-term effects through rigorous research, clinical trials, and regulatory protocols. Ongoing studies are shedding light on the mechanisms and possibilities of stem cell therapy, instilling hope that we can conquer the challenge of managing Alzheimer's disease.

Keywords: Stem Cells; Alzheimer's Disease; Disease Management; Regenerative Medicine; Neurodegenerative Disorders; Therapeutic Potential; Cell-Based Therapies; Neural Regeneration; Innovative Treatments; Research Advancements; Neurological Disorders; Stem Cell Therapy; Precision Medicine; Neural Stem Cells; Clinical Trials; Neuroprotection

  1. A Patel S., et al. “Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity?” Current Pharmacogenomics and Personalized Medicine1 (2010): 25-36.
  2. Abernethy Amy., et al. “The Promise of Digital Health: Then, Now, and the Future”. NAM Perspectives22 (2022).
  3. Akobeng Anthony K. “Assessing the Validity of Clinical Trials”. Journal of Pediatric Gastroenterology and Nutrition3 (2008): 277-282.
  4. Alberti Contardo. Tissue Engineering: Technological Advances to Improve Its Applications in Reconstructive Surgery 33.11-12 (2012): 435-443.
  5. ALEXANDRU Adriana and Marilena IANCULESCU. “Enabling Assistive Technologies to Shape the Future of the Intensive Senior-Centred Care: A Case Study Approach”. Studies in Informatics and Control3 (2017).
  6. Alfano Catherine M., et al. “An Action Plan for Translating Cancer Survivorship Research into Care”. JNCI Journal of the National Cancer Institute11 (2014).
  7. Alvarez Clara V., et al. “Defining Stem Cell Types: Understanding the Therapeutic Potential of ESCs, ASCs, and IPS Cells”. Journal of Molecular Endocrinology2 (2012): R89-R111.
  8. Aly Riham Mohamed. “Current State of Stem Cell-Based Therapies: An Overview”. Stem Cell Investigation8 (2020): 8-8.
  9. Andrews Melissa R and Lindsey H Forbes. “Advances in Human Stem Cell Therapies: Pre-Clinical Studies and the Outlook for Central Nervous System Regeneration”. Neural Regeneration Research4 (2021): 614.
  10. Aristidis Vrahatis., et al. “Revolutionizing the Early Detection of Alzheimer’s Disease through Non-Invasive Biomarkers: The Role of Artificial Intelligence and Deep Learning”. MDPI Open Access Journals9 (2023): 4184-4184.
  11. Ashfaq Ul Hassan., et al. “Role of Stem Cells in Treatment of Neurological Disorder”. International Journal of Health Sciences (2009).
  12. Badowski Melissa., et al. “Engaging in Collaborative Research: Focus on the Pharmacy Practitioner”. Hospital Pharmacy1 (2017): 33-43.
  13. Bai Xiaowen. “Stem Cell-Based Disease Modeling and Cell Therapy”. Cells10 (2020): 2193.
  14. Bashor Caleb J., et al. “Engineering the next Generation of Cell-Based Therapeutics”. Nature Reviews Drug Discovery9 (2022): 655-675.
  15. Blum Barak and Nissim Benvenisty. “The Tumorigenicity of Human Embryonic Stem Cells”. Advances in Cancer Research 100 (2008): 133-158.
  16. Blurton-Jones M., et al. “Neural Stem Cells Improve Cognition via BDNF in a Transgenic Model of Alzheimer Disease”. Proceedings of the National Academy of Sciences32 (2009): 13594-13599.
  17. Boese Austin C., et al. “Neural Stem Cell Therapy for Subacute and Chronic Ischemic Stroke”. Stem Cell Research and Therapy1 (2018).
  18. Boland Mary Regina., et al. “Ten Simple Rules to Enable Multi-Site Collaborations through Data Sharing”. PLOS Computational Biology1 (2017): e1005278.
  19. Bombard Yvonne., et al. “Engaging Patients to Improve Quality of Care: A Systematic Review”. Implementation Science1 (2018): 1-22.
  20. Bozeman Barry., et al. “Research Collaboration in Universities and Academic Entrepreneurship: The (2013).
  21. Carroll Jennifer K., et al. “Enhancing International Collaboration among Early Career Researchers”. Patient Education and Counseling3 (2010): 417-420.
  22. Chen Jiahui., et al. “Safety and Efficacy of Stem Cell Therapy: An Overview Protocol on Published Meta-Analyses and Evidence Mapping”. Annals of Translational Medicine3 (2021): 270-270.
  23. Choi Jimmy and Elizabeth W Twamley. “Cognitive Rehabilitation Therapies for Alzheimer’s Disease: A Review of Methods to Improve Treatment Engagement and Self-Efficacy”. Neuropsychology Review1 (2013): 48-62.
  24. Christ George J., et al. “The Pharmacology of Regenerative Medicine”. Pharmacological Reviews3 (2013): 1091-1133.
  25. Cooper Lisa A., et al. “Designing and Evaluating Interventions to Eliminate Racial and Ethnic Disparities in Health Care”. Journal of General Internal Medicine6 (2002): 477-486.
  26. Côté Geneviève., et al. “Environmental Scan of Interprofessional Collaborative Practice Initiatives”. Journal of Interprofessional Care5 (2008): 449-460.
  27. Cummings Jeffrey., et al. “Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future”. Journal of Alzheimer’s Diseases1 (2018): S3-S22.
  28. Jeffrey Cummings. “The Role of Biomarkers in Alzheimer’s Disease Drug Development”. Advances in Experimental Medicine and Biology (2019): 29-61.
  29. Curran Geoffrey M., et al. “Effectiveness-Implementation Hybrid Designs”. Medical Care3 (2012): 217-226.
  30. Cutler NR and JJ Sramek. “Scientific and Ethical Concerns in Clinical Trials in Alzheimer’s Patients: The Bridging Study”. European Journal of Clinical Pharmacology6 (1995).
  31. Daley George Q. “The Promise and Perils of Stem Cell Therapeutics”. Cell Stem Cell6 (2012): 740-749.
  32. De Masi Claudia., et al. “Application of CRISPR/Cas9 to Human-Induced Pluripotent Stem Cells: From Gene Editing to Drug Discovery”. Human Genomics1 (2020).
  33. Dhana Klodian., et al. “Healthy Lifestyle and the Risk of Alzheimer Dementia: Findings from 2 Longitudinal Studies”. Neurology4 (2020).
  34. Dubois Bruno., et al. “Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria”. Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association3 (2016): 292-323.
  35. Fanaroff Alexander C., et al. Methods for Safety and Endpoint Ascertainment: Identification of Adverse Events through Scrutiny of Negatively Adjudicated Events 21.1 (2020).
  36. Fang Yi., et al. “Recent Advances: Decoding Alzheimer’s Disease with Stem Cells”. Frontiers in Aging Neuroscience 10 (2018).
  37. Fayazi Nashmin., et al. “Stem Cell-Derived Exosomes: A New Strategy of Neurodegenerative Disease Treatment”. Molecular Neurobiology (2021).
  38. Flicker Leon. “Modifiable Lifestyle Risk Factors for Alzheimer’s Disease”. Journal of Alzheimer’s Disease3 (2010): 803-811.
  39. Fouad Ghadha Ibrahim. “Stem Cells as a Promising Therapeutic Approach for Alzheimer’s Disease: A Review”. Bulletin of the National Research Centre1 (2019).
  40. Geese Franziska and Kai-Uwe Schmitt. “Interprofessional Collaboration in Complex Patient Care Transition: A Qualitative Multi-Perspective Analysis”. Healthcare3 (2023): 359.
  41. George Bobby. “Regulations and Guidelines Governing Stem Cell Based Products: Clinical Considerations”. Perspectives in Clinical Research3 (2011): 94.
  42. Glotzbach Jason., et al. “Delivery Strategies for Stem Cell-Based Therapy”. Journal of Healthcare Engineering1 (2012): 1-20.
  43. Goetz Laura H and Nicholas J Schork. “Personalized Medicine: Motivation, Challenges, and Progress”. Fertility and Sterility6 (2018): 952-963.
  44. Gray JA., et al. “Conditionally Immortalized, Multipotential and Multifunctional Neural Stem Cell Lines as an Approach to Clinical Transplantation”. Cell Transplantation2 (2000): 153-168.
  45. Green Bart N and Claire D Johnson. “Interprofessional Collaboration in Research, Education, and Clinical Practice: Working Together for a Better Future”. Journal of Chiropractic Education1 (2015): 1-10.
  46. Grossberg GT and AK Desai. “Management of Alzheimer’s Disease”. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences4 (2003): M331-M353.
  47. Hassan Waqar Ul., et al. “Role of Adipose-Derived Stem Cells in Wound Healing”. Wound Repair and Regeneration3 (2014): 313-325.
  48. Hemkens Lars G., et al. “Routinely Collected Data and Comparative Effectiveness Evidence: Promises and Limitations”. Canadian Medical Association Journal8 (2016): E158-E164.
  49. Ho Dean., et al. “Enabling Technologies for Personalized and Precision Medicine”. Trends in Biotechnology5 (2020): 497-518.
  50. Hoang Duc M., et al. “Stem Cell-Based Therapy for Human Diseases”. Signal Transduction and Targeted Therapy1 (2022): 1-41.
  51. Hobin Jennifer A., et al. “Engaging Basic Scientists in Translational Research: Identifying Opportunities, Overcoming Obstacles”. Journal of Translational Medicine1 (2012).
  52. Hockemeyer Dirk and Rudolf Jaenisch. “Induced Pluripotent Stem Cells Meet Genome Editing”. Cell Stem Cell5 (2016): 573-586.
  53. Holmes Leah., et al. “Innovating Public Engagement and Patient Involvement through Strategic Collaboration and Practice”. Research Involvement and Engagement1 (2019).
  54. Howe Edmund G. “Ethical Issues in Diagnosing and Treating Alzheimer Disease”. Psychiatry (2006).
  55. Hu Bao-Yang., et al. “Neural Differentiation of Human Induced Pluripotent Stem Cells Follows Developmental Principles but with Variable Potency”. Proceedings of the National Academy of Sciences of the United States of America9 (2010): 4335-4340.
  56. Imran Siti AM., et al. “Regenerative Medicine Therapy in Malaysia: An Update”. Frontiers in Bioengineering and Biotechnology 10 (2022).
  57. Issa Amalia M. “Personalized Medicine and the Practice of Medicine in the 21st Century”. McGill Journal of Medicine1 (2020).
  58. Jasvinder Singh Bhatti., et al. “Stem Cells in the Treatment of Alzheimer’s Disease - Promises and Pitfalls”. Biochimica et Biophysica Acta: Molecular Basis of Disease6 (2023): 166712-166712.
  59. Jessen Frank. “Früherkennung Der Alzheimer-Krankheit Und Ansätze Der Prävention”. SpringerLink3 (2019): 255-260.
  60. Joyce Nanette., et al. “Mesenchymal Stem Cells for the Treatment of Neurodegenerative Disease”. Regenerative Medicine6 (2010): 933-946.
  61. Kadam Rashmi Ashish. “Informed Consent Process: A Step Further towards Making It Meaningful!” Perspectives in Clinical Research3 (2017): 107-112.
  62. Karathanasis SK. “Regenerative Medicine: Transforming the Drug Discovery and Development Paradigm”. Cold Spring Harbor Perspectives in Medicine8 (2014): a014084-a014084.
  63. Karvelas Nikolaos., et al. “Advances in Stem Cell Therapy in Alzheimer’s Disease: A Comprehensive Clinical Trial Review”. Stem Cell Investigation (2022): 2-2.
  64. Kelly Sarah., et al. “Dementia Priority Setting Partnership with the James Lind Alliance: Using Patient and Public Involvement and the Evidence Base to Inform the Research Agenda”. Age and Ageing6 (2015): 985-993.
  65. Kim Il-Kwon., et al. “Recent Advances in Stem Cell Therapy for Neurodegenerative Disease: Three Dimensional Tracing and Its Emerging Use”. World Journal of Stem Cells9 (2021): 1215-1230.
  66. Kimbrel Erin A and Robert Lanza. “Next-Generation Stem Cells - Ushering in a New Era of Cell-Based Therapies”. Nature Reviews Drug Discovery (2020).
  67. King Nancy MP and Jacob Perrin. “Ethical Issues in Stem Cell Research and Therapy”. Stem Cell Research and Therapy4 (2014): 85.
  68. Kivipelto Miia., et al. “Lifestyle Interventions to Prevent Cognitive Impairment, Dementia and Alzheimer Disease”. Nature Reviews Neurology11 (2018): 653-666.
  69. Klimova Blanka., et al. “Exploring Assistive Technology as a Potential Beneficial Intervention Tool for People with Alzheimer’s Disease - a Systematic Review”. Neuropsychiatric Disease and Treatment Volume 14 (2018): 3151-3158.
  70. Krzyszczyk Paulina., et al. “The Growing Role of Precision and Personalized Medicine for Cancer Treatment”. TECHNOLOGY03n04 (2018): 79-100.
  71. Kurz Alexander and Robert Perneczky. “Novel Insights for the Treatment of Alzheimer’s Disease”. Progress in Neuro-Psychopharmacology and Biological Psychiatry2 (2011): 373-379.
  72. Kwak Kyeong-Ah., et al. “Current Perspectives Regarding Stem Cell-Based Therapy for Alzheimer’s Disease”. Stem Cells International (2018): 1-14.
  73. Lane CA., et al. “Alzheimer’s Disease”. European Journal of Neurology1 (2017): 59-70.
  74. Lars Assen., et al. “Roles and Responsibilities in Stem Cell Research: A Focus Group Study with Stem Cell Researchers and Patients”. Regenerative Medicine7 (2022): 445-459.
  75. Lexchin Joel., et al. “Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of COVID-19”. International Journal of Health Services1 (2020): 5-13.
  76. Liu Donghui., et al. Coating Materials for Neural Stem/Progenitor Cell Culture and Differentiation 29.8 (2020): 463-474.
  77. Liu Xin-Yu., et al. “Stem Cell Therapy for Alzheimer’s Disease”. World Journal of Stem Cells8 (2020): 787-802.
  78. Lo Bernard and Lindsay Parham. “Ethical Issues in Stem Cell Research”. Endocrine Reviews3 (2009): 204-213.
  79. Logsdon Rebecca G., et al. Evidence-Based Interventions to Improve Quality of Life for Individuals with Dementia (2007).
  80. Lovell-Badge Robin., et al. “ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 Update”. Stem Cell Reports6 (2021): 1398-1408.
  81. Mahla Ranjeet Singh. “Stem Cells Applications in Regenerative Medicine and Disease Therapeutics”. International Journal of Cell Biology 6940283 (2016): 1-24.
  82. Mahoney Diane F., et al. “In-Home Monitoring of Persons with Dementia: Ethical Guidelines for Technology Research and Development”. Alzheimer’s and Dementia3 (2007): 217-226.
  83. Maldonado-Soto Angel R., et al. “Stem Cells in the Nervous System”. American Journal of Physical Medicine and Rehabilitation 93 (2014): S132-S144.
  84. Masahiko Abematsu., et al. “Neurons Derived from Transplanted Neural Stem Cells Restore Disrupted Neuronal Circuitry in a Mouse Model of Spinal Cord Injury”. The Journal of Clinical Investigation9 (2010): 3255-3266.
  85. Masoumeh Mousavinejad., et al. “Current Biosafety Considerations in Stem Cell Therapy”. Cell Journal2 (2016): 281-287.
  86. Mitchell S., et al. “The Future of Dementia Risk Reduction Research: Barriers and Solutions”. Journal of Public Health4 (2016).
  87. Moradi Sharif., et al. “Research and Therapy with Induced Pluripotent Stem Cells (IPSCs): Social, Legal, and Ethical Considerations”. Stem Cell Research and Therapy1 (2019).
  88. Mucke Lennart. “Neuroscience: Alzheimer’s Disease”. Nature7266 (2009): 895-897.
  89. National Academies of Sciences, Engineering, And Medicine (U.S.). Committee On Responsible Science. Fostering Integrity in Research. Washington, National Academies Press (2017).
  90. Nazem Amir and G Ali Mansoori. “Nanotechnology Solutions for Alzheimer’s Disease: Advances in Research Tools, Diagnostic Methods and Therapeutic Agents”. Journal of Alzheimer’s Disease2 (2008): 199-223.
  91. Nielsen Bo Bernhard. “The Role of Trust in Collaborative Relationships: A Multi-Dimensional Approach”. M@N@Gement3 (2004): 239.
  92. Nyström ME., et al. “Collaborative and Partnership Research for Improvement of Health and Social Services: Researcher’s Experiences from 20 Projects”. Health Research Policy and Systems1 (2018).
  93. Pais Marcos., et al. “Early Diagnosis and Treatment of Alzheimer’s Disease: New Definitions and Challenges”. Brazilian Journal of Psychiatry4 (2020).
  94. Pappadà Alessandro., et al. “Assistive Technologies in Dementia Care: An Updated Analysis of the Literature”. Frontiers in Psychology 12 (2021).
  95. Pardo-Moreno Teresa., et al. “Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives”. Pharmaceutics6 (2022): 1117.
  96. Petersen Alan., et al. “Choice”. Hope, and Stem Cell Treatments (2017).
  97. Petrosyan Astgik., et al. “Regenerative Medicine Applications: An Overview of Clinical Trials”. Frontiers in Bioengineering and Biotechnology 10 (2022).
  98. Pistollato Francesca., et al. “Alzheimer Disease Research in the 21st Century: Past and Current Failures, New Perspectives and Funding Priorities”. Oncotarget26 (2016).
  99. Powell Walter W., et al. “Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology”. Administrative Science Quarterly1 (1996): 116-145.
  100. Pushparajah Daphnee S., et al. “EUPATI: Collaboration between Patients, Academia and Industry to Champion the Informed Patient in the Research and Development of Medicines”. Journal of Medicines Development Sciences1 (2016): 74.
  101. Rahman MD., et al. “Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives”. Biology1 (2022): 147.
  102. Reeves Scott., et al. “Interprofessional Collaboration to Improve Professional Practice and Healthcare Outcomes”. Cochrane Database of Systematic Reviews6 (2017).
  103. Ruiz-Lozano Pilar and Prithi Rajan. “Stem Cells as in Vitro Models of Disease”. Benthom Science4 (2007).
  104. Salwa and Lalit Kumar. “Engrafted Stem Cell Therapy for Alzheimer’s Disease: A Promising Treatment Strategy with Clinical Outcome”. Journal of Controlled Release 338 (2021): 837-857.
  105. Schillaci Orazio and Nicoletta Urbano. “Digital PET/CT: A New Intriguing Chance for Clinical Nuclear Medicine and Personalized Molecular Imaging”. European Journal of Nuclear Medicine and Molecular Imaging6 (2019): 1222-1225.
  106. Schork Nicholas J. “Artificial Intelligence and Personalized Medicine”. Precision Medicine in Cancer Therapy (2019): 265-283.
  107. Scott Troy J., et al. “Economic Analysis of Opportunities to Accelerate Alzheimer’s Disease Research and Development”. Annals of the New York Academy of Sciences1 (2014): 17-34.
  108. Shi Yanhong., et al. “Induced Pluripotent Stem Cell Technology: A Decade of Progress”. Nature Reviews Drug Discovery2 (2016): 115-130.
  109. Silva Jose., et al. “Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition”. PLoS Biology10 (2008): e253.
  110. Simon Richard. “Genomic Biomarkers in Predictive Medicine. An Interim Analysis”. EMBO Molecular Medicine8 (2011): 429-435.
  111. Sivandzade Farzane and Luca Cucullo. “Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview”. International Journal of Molecular Sciences4 (2021): 2153.
  112. Strianese Oriana., et al. “Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease”. Genes7 (2020).
  113. Stuart Brad., et al. “Finding Hope and Healing When Cure Is Not Possible”. Mayo Clinic Proceedings4 (2019): 677-685.
  114. Tang Jun. “How Close Is the Stem Cell Cure to the Alzheimer’s Disease: Future and Beyond?” Neural Regeneration Research1 (2012): 66-71.
  115. Tang Shijie., et al. “Molecular Biomarkers, Network Biomarkers, and Dynamic Network Biomarkers for Diagnosis and Prediction of Rare Diseases”. Fundamental Research 3 (2011).
  116. “The Promise of Stem Cells”. Nature Neuroscience10 (2004): 1013-1013.
  117. The Transforming Landscape of Dementia Research 3.5 (2023): 459-459.
  118. Tong Leslie M., et al. “Stem Cell Therapy for Alzheimer’s Disease and Related Disorders: Current Status and Future Perspectives”. Experimental and Molecular Medicine3 (2015): e151-e151.
  119. Ullah Mujib., et al. “Applications of Artificial Intelligence In, Early Detection of Cancer, Clinical Diagnosis and Personalized Medicine”. WArtificial Intelligence in Cancer2 (2020): 39-44.
  120. Ursin Frank., et al. “Ethical Implications of Alzheimer’s Disease Prediction in Asymptomatic Individuals through Artificial Intelligence”. Diagnostics3 (2021): 440.
  121. Van Der Schee Marc., et al. “Breath Biopsy for Early Detection and Precision Medicine in Cancer”. Ecancermedicalscience 12 (2018).
  122. Volarevic Vladislav., et al. “Ethical and Safety Issues of Stem Cell-Based Therapy”. International Journal of Medical Sciences1 (2018): 36-45.
  123. Watson Jennifer L., et al. “Obstacles and Opportunities in Alzheimer’s Clinical Trial Recruitment”. Health Affairs4 (2014): 574-579.
  124. Weiss Andreas M., et al. “Ethical Considerations on Stem Cell Research”. Pluripotent Stem Cell (2013).
  125. Yiannopoulou Konstantina G and Sokratis G Papageorgiou. “Current and Future Treatments in Alzheimer Disease: An Update”. Journal of Central Nervous System Disease1 (2020): 117957352090739.
  126. Zakrzewski Wojciech., et al. “Stem Cells: Past, Present, and Future”. Stem Cell Research and Therapy1 (2019).
  127. Zucchella Chiara., et al. “The Multidisciplinary Approach to Alzheimer’s Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment”. Frontiers in Neurology1058 (2018).

Talha Sultan., et al. “Unlocking the Power of Stem Cells: Revolutionizing Alzheimer’s Disease Management with Cutting-Edge Solutions”. EC Neurology  15.6 (2023): 05-19.